US Stock MarketDetailed Quotes

Avadel Pharmaceuticals (AVDL)

Watchlist
  • 21.530
  • 0.0000.00%
Trading Jan 23 12:15 ET
2.11BMarket Cap0.00P/E (TTM)

Avadel Pharmaceuticals (AVDL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
422.28%22.21M
169.82%12.7M
72.29%-8.23M
63.50%-46.91M
128.09%7.87M
81.98%-6.89M
43.21%-18.19M
1.75%-29.7M
-82.79%-128.51M
-82.41%-28.03M
Net income from continuing operations
100.76%20K
169.92%9.67M
82.01%-4.92M
69.53%-48.83M
82.48%-5.04M
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
Operating gains losses
----
----
----
----
----
----
----
----
--13.13M
--0
Depreciation and amortization
7.73%1.12M
144.39%1.07M
52.50%825K
51.81%2.68M
3,811.11%668K
73.95%1.04M
-27.29%437K
-7.99%541K
18.29%1.77M
-103.07%-18K
Deferred tax
----
----
----
--0
----
----
----
----
--0
----
Other non cash items
12,552.56%19.74M
-75.05%-856K
109.74%70K
-120.40%-828K
-86.10%224K
383.64%156K
-177.62%-489K
-138.41%-719K
-49.86%4.06M
-34.00%1.61M
Change In working capital
66.99%-3.59M
74.35%-2.51M
-10.79%-8.39M
-577.39%-20.32M
281.40%7.9M
-93.38%-10.87M
-193.94%-9.77M
-120.72%-7.57M
-112.22%-3M
-162.01%-4.35M
-Change in receivables
51.33%-1.81M
108.89%950K
29.32%-7.48M
-81.72%-21.99M
151.24%3.01M
43.48%-3.73M
-3,135.51%-10.69M
---10.59M
---12.1M
-21,618.52%-5.86M
-Change in inventory
77.23%-681K
-228.19%-3.3M
94.76%-66K
3.28%-9.22M
6.64%-3.96M
22.25%-2.99M
30.23%-1M
---1.26M
---9.53M
---4.25M
-Change in prepaid assets
1,551.72%842K
-86.48%612K
50.41%-3.02M
119.30%416K
93.80%2.03M
-104.85%-58K
1,782.16%4.53M
-47.23%-6.08M
-106.96%-2.16M
-65.09%1.05M
-Change in payables and accrued expense
23.72%-1.28M
192.28%2.86M
-81.75%2M
-33.12%12.33M
54.99%6.17M
-196.56%-1.68M
-126.03%-3.1M
1,241.05%10.94M
739.95%18.44M
-11.00%3.98M
-Change in other working capital
72.95%-652K
-845.79%-3.63M
130.60%179K
-178.55%-1.85M
-9.60%659K
-228.19%-2.41M
450.36%487K
-404.31%-585K
166.61%2.35M
271.53%729K
Cash from discontinued investing activities
Operating cash flow
422.28%22.21M
169.82%12.7M
72.29%-8.23M
63.50%-46.91M
128.09%7.87M
81.98%-6.89M
43.21%-18.19M
1.75%-29.7M
-82.79%-128.51M
-82.41%-28.03M
Investing cash flow
Cash flow from continuing investing activities
-271.05%-8.43M
-178.24%-8.25M
-42.41%12.32M
203.37%51.78M
-46.60%14.91M
-49.80%4.93M
111.36%10.55M
322.17%21.39M
-162.85%-50.09M
22.09%27.93M
Net PPE purchase and sale
---9K
----
----
--0
--0
--0
----
----
--0
----
Net investment purchase and sale
33.39%6.58M
-176.52%-8.07M
-42.41%12.32M
203.37%51.78M
-46.60%14.91M
-49.80%4.93M
111.36%10.55M
322.17%21.39M
-162.29%-50.09M
22.09%27.93M
Cash from discontinued investing activities
Investing cash flow
-271.05%-8.43M
-178.24%-8.25M
-42.41%12.32M
203.37%51.78M
-46.60%14.91M
-49.80%4.93M
111.36%10.55M
322.17%21.39M
-162.85%-50.09M
22.09%27.93M
Financing cash flow
Cash flow from continuing financing activities
113.00%2.51M
35.82%982K
-94.77%690K
-88.20%15.97M
104.17%880K
-96.14%1.18M
-99.21%723K
-61.70%13.19M
830.59%135.34M
-418.80%-21.11M
Net issuance payments of debt
----
----
----
--0
--0
--0
--0
--0
-346.84%-38.67M
-144.60%-21.17M
Net common stock issuance
--0
--0
--0
-93.67%9.25M
--0
--0
--0
-22.35%9.25M
476.92%146.06M
-99.99%2K
Net preferred stock issuance
----
----
----
----
----
----
----
--0
----
----
Proceeds from stock option exercised by employees
113.00%2.51M
35.82%982K
-82.49%690K
193.07%6.72M
1,592.31%880K
154.76%1.18M
-58.69%723K
13,486.21%3.94M
-14.50%2.29M
-89.39%52K
Net other financing activities
----
----
----
----
----
----
----
----
633.78%25.64M
--0
Cash from discontinued financing activities
Financing cash flow
113.00%2.51M
35.82%982K
-94.77%690K
-88.20%15.97M
104.17%880K
-96.14%1.18M
-99.21%723K
-61.70%13.19M
830.59%135.34M
-418.80%-21.11M
Net cash flow
Beginning cash position
119.79%63.4M
57.48%56.37M
64.82%51.37M
-57.87%31.17M
-44.83%28.58M
-42.29%28.85M
-57.08%35.79M
-57.87%31.17M
45.90%73.98M
-14.67%51.81M
Current changes in cash
2,179.05%16.28M
178.48%5.43M
-2.01%4.78M
148.17%20.84M
211.57%23.67M
-138.10%-783K
79.29%-6.91M
-47.46%4.87M
-280.76%-43.27M
-250.11%-21.21M
Effect of exchange rate changes
-74.52%132K
4,826.47%1.61M
191.06%224K
-240.44%-639K
-254.40%-877K
326.20%518K
-78.95%-34K
-282.22%-246K
168.52%455K
165.66%568K
End cash Position
179.24%79.81M
119.79%63.4M
57.48%56.37M
64.82%51.37M
64.82%51.37M
-44.83%28.58M
-42.29%28.85M
-57.08%35.79M
-57.87%31.17M
-57.87%31.17M
Free cash flow
204.44%7.2M
168.82%12.52M
72.29%-8.23M
63.50%-46.91M
128.09%7.87M
81.98%-6.89M
43.21%-18.19M
1.75%-29.7M
-80.95%-128.51M
-82.41%-28.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 422.28%22.21M169.82%12.7M72.29%-8.23M63.50%-46.91M128.09%7.87M81.98%-6.89M43.21%-18.19M1.75%-29.7M-82.79%-128.51M-82.41%-28.03M
Net income from continuing operations 100.76%20K169.92%9.67M82.01%-4.92M69.53%-48.83M82.48%-5.04M92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M
Operating gains losses ----------------------------------13.13M--0
Depreciation and amortization 7.73%1.12M144.39%1.07M52.50%825K51.81%2.68M3,811.11%668K73.95%1.04M-27.29%437K-7.99%541K18.29%1.77M-103.07%-18K
Deferred tax --------------0------------------0----
Other non cash items 12,552.56%19.74M-75.05%-856K109.74%70K-120.40%-828K-86.10%224K383.64%156K-177.62%-489K-138.41%-719K-49.86%4.06M-34.00%1.61M
Change In working capital 66.99%-3.59M74.35%-2.51M-10.79%-8.39M-577.39%-20.32M281.40%7.9M-93.38%-10.87M-193.94%-9.77M-120.72%-7.57M-112.22%-3M-162.01%-4.35M
-Change in receivables 51.33%-1.81M108.89%950K29.32%-7.48M-81.72%-21.99M151.24%3.01M43.48%-3.73M-3,135.51%-10.69M---10.59M---12.1M-21,618.52%-5.86M
-Change in inventory 77.23%-681K-228.19%-3.3M94.76%-66K3.28%-9.22M6.64%-3.96M22.25%-2.99M30.23%-1M---1.26M---9.53M---4.25M
-Change in prepaid assets 1,551.72%842K-86.48%612K50.41%-3.02M119.30%416K93.80%2.03M-104.85%-58K1,782.16%4.53M-47.23%-6.08M-106.96%-2.16M-65.09%1.05M
-Change in payables and accrued expense 23.72%-1.28M192.28%2.86M-81.75%2M-33.12%12.33M54.99%6.17M-196.56%-1.68M-126.03%-3.1M1,241.05%10.94M739.95%18.44M-11.00%3.98M
-Change in other working capital 72.95%-652K-845.79%-3.63M130.60%179K-178.55%-1.85M-9.60%659K-228.19%-2.41M450.36%487K-404.31%-585K166.61%2.35M271.53%729K
Cash from discontinued investing activities
Operating cash flow 422.28%22.21M169.82%12.7M72.29%-8.23M63.50%-46.91M128.09%7.87M81.98%-6.89M43.21%-18.19M1.75%-29.7M-82.79%-128.51M-82.41%-28.03M
Investing cash flow
Cash flow from continuing investing activities -271.05%-8.43M-178.24%-8.25M-42.41%12.32M203.37%51.78M-46.60%14.91M-49.80%4.93M111.36%10.55M322.17%21.39M-162.85%-50.09M22.09%27.93M
Net PPE purchase and sale ---9K----------0--0--0----------0----
Net investment purchase and sale 33.39%6.58M-176.52%-8.07M-42.41%12.32M203.37%51.78M-46.60%14.91M-49.80%4.93M111.36%10.55M322.17%21.39M-162.29%-50.09M22.09%27.93M
Cash from discontinued investing activities
Investing cash flow -271.05%-8.43M-178.24%-8.25M-42.41%12.32M203.37%51.78M-46.60%14.91M-49.80%4.93M111.36%10.55M322.17%21.39M-162.85%-50.09M22.09%27.93M
Financing cash flow
Cash flow from continuing financing activities 113.00%2.51M35.82%982K-94.77%690K-88.20%15.97M104.17%880K-96.14%1.18M-99.21%723K-61.70%13.19M830.59%135.34M-418.80%-21.11M
Net issuance payments of debt --------------0--0--0--0--0-346.84%-38.67M-144.60%-21.17M
Net common stock issuance --0--0--0-93.67%9.25M--0--0--0-22.35%9.25M476.92%146.06M-99.99%2K
Net preferred stock issuance ------------------------------0--------
Proceeds from stock option exercised by employees 113.00%2.51M35.82%982K-82.49%690K193.07%6.72M1,592.31%880K154.76%1.18M-58.69%723K13,486.21%3.94M-14.50%2.29M-89.39%52K
Net other financing activities --------------------------------633.78%25.64M--0
Cash from discontinued financing activities
Financing cash flow 113.00%2.51M35.82%982K-94.77%690K-88.20%15.97M104.17%880K-96.14%1.18M-99.21%723K-61.70%13.19M830.59%135.34M-418.80%-21.11M
Net cash flow
Beginning cash position 119.79%63.4M57.48%56.37M64.82%51.37M-57.87%31.17M-44.83%28.58M-42.29%28.85M-57.08%35.79M-57.87%31.17M45.90%73.98M-14.67%51.81M
Current changes in cash 2,179.05%16.28M178.48%5.43M-2.01%4.78M148.17%20.84M211.57%23.67M-138.10%-783K79.29%-6.91M-47.46%4.87M-280.76%-43.27M-250.11%-21.21M
Effect of exchange rate changes -74.52%132K4,826.47%1.61M191.06%224K-240.44%-639K-254.40%-877K326.20%518K-78.95%-34K-282.22%-246K168.52%455K165.66%568K
End cash Position 179.24%79.81M119.79%63.4M57.48%56.37M64.82%51.37M64.82%51.37M-44.83%28.58M-42.29%28.85M-57.08%35.79M-57.87%31.17M-57.87%31.17M
Free cash flow 204.44%7.2M168.82%12.52M72.29%-8.23M63.50%-46.91M128.09%7.87M81.98%-6.89M43.21%-18.19M1.75%-29.7M-80.95%-128.51M-82.41%-28.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More